KinoML is an AI model developed by Charité-Universitätsmedizin Berlin, Saarland University and Memorial Sloan Kettering Cancer Center (Germany and United States), first published in September 2024. It works in the biology domain, on tasks such as drug discovery and protein-ligand binding affinity prediction.
Epoch AI has no training-compute estimate for this model.
Access: Unreleased. Its weights are not openly released. Epoch AI rates the confidence of this record as confident.